Literature DB >> 20707315

Enhanced uptake of porous silica microparticles by bifunctional surface modification with a targeting antibody and a biocompatible polymer.

Kai Cheng1, Steven R Blumen, Maximilian B MacPherson, Jeremy L Steinbacher, Brooke T Mossman, Christopher C Landry.   

Abstract

Strategies were developed by which mesoporous microparticles were modified on their external surfaces with tetraethylene glycol (TEG), a protein, or both, leaving the pore surfaces available for modification with a separate moiety, such as a dye. Only particles bifunctionally modified with both TEG and a cell-specific antibody were taken up specifically by a targeted cancer cell line. In contrast to similarly functionalized nanoparticles, endocytosed microparticles were not contained within a lysosome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20707315      PMCID: PMC2947489          DOI: 10.1021/am100530t

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  38 in total

Review 1.  Inhaled amorphous silica particulates: what do we know about their toxicological profiles?

Authors:  D B Warheit
Journal:  J Environ Pathol Toxicol Oncol       Date:  2001       Impact factor: 3.567

Review 2.  Effect of pegylation on pharmaceuticals.

Authors:  J Milton Harris; Robert B Chess
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

3.  Biodegradation and biocompatibility of PLA and PLGA microspheres.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-10-13       Impact factor: 15.470

Review 4.  Current methods for attaching targeting ligands to liposomes and nanoparticles.

Authors:  Leila Nobs; Franz Buchegger; Robert Gurny; Eric Allémann
Journal:  J Pharm Sci       Date:  2004-08       Impact factor: 3.534

5.  Size-exclusion chromatography of low-molecular-mass polymers using mesoporous silica.

Authors:  Terry Nassivera; Andrew G Eklund; Christopher C Landry
Journal:  J Chromatogr A       Date:  2002-10-11       Impact factor: 4.759

6.  Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica.

Authors:  C J Johnston; K E Driscoll; J N Finkelstein; R Baggs; M A O'Reilly; J Carter; R Gelein; G Oberdörster
Journal:  Toxicol Sci       Date:  2000-08       Impact factor: 4.849

7.  Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.

Authors:  Justin M Saul; Ananth Annapragada; Jayaganesh V Natarajan; Ravi V Bellamkonda
Journal:  J Control Release       Date:  2003-09-19       Impact factor: 9.776

8.  Nanocrystal targeting in vivo.

Authors:  Maria E Akerman; Warren C W Chan; Pirjo Laakkonen; Sangeeta N Bhatia; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

Review 9.  Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.

Authors:  Alberto Gabizon; Hilary Shmeeda; Yechezkel Barenholz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 10.  Mesothelin: a new target for immunotherapy.

Authors:  Raffit Hassan; Tapan Bera; Ira Pastan
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

View more
  10 in total

1.  A multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomas.

Authors:  Sherrill L Macura; Jedd M Hillegass; Jeremy L Steinbacher; Maximilian B MacPherson; Arti Shukla; Stacie L Beuschel; Timothy N Perkins; Kelly J Butnor; Melissa J Lathrop; Mutlay Sayan; Khan Hekmatyar; Douglas J Taatjes; Risto A Kauppinen; Christopher C Landry; Brooke T Mossman
Journal:  J Histochem Cytochem       Date:  2012-06-21       Impact factor: 2.479

Review 2.  Theragnostic potentials of core/shell mesoporous silica nanostructures.

Authors:  Aswathy Ravindran Girija; Sivakumar Balasubramanian
Journal:  Nanotheranostics       Date:  2019-01-01

3.  Gd-labeled microparticles in MRI: in vivo imaging of microparticles after intraperitoneal injection.

Authors:  Jeremy L Steinbacher; Sherrill A Lathrop; Kai Cheng; Jedd M Hillegass; Kelly J Butnor; Risto A Kauppinen; Brooke T Mossman; Christopher C Landry
Journal:  Small       Date:  2010-12-06       Impact factor: 13.281

Review 4.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

5.  Adsorption and release of siRNA from porous silica.

Authors:  Jeremy L Steinbacher; Christopher C Landry
Journal:  Langmuir       Date:  2013-10-23       Impact factor: 3.882

6.  Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts.

Authors:  Sherrill L Macura; Jeremy L Steinbacher; Maximilian B Macpherson; Melissa J Lathrop; Mutlay Sayan; Jedd M Hillegass; Stacie L Beuschel; Timothy N Perkins; Page C Spiess; Albert van der Vliet; Kelly J Butnor; Arti Shukla; Marilyn Wadsworth; Christopher C Landry; Brooke T Mossman
Journal:  BMC Cancer       Date:  2013-09-11       Impact factor: 4.430

Review 7.  Smart Mesoporous Nanomaterials for Antitumor Therapy.

Authors:  Marina Martínez-Carmona; Montserrat Colilla; Maria Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2015-11-06       Impact factor: 5.076

Review 8.  Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights.

Authors:  María Vallet-Regí; Montserrat Colilla; Isabel Izquierdo-Barba; Miguel Manzano
Journal:  Molecules       Date:  2017-12-25       Impact factor: 4.411

Review 9.  Gold Nanoparticles: A Powerful Tool to Visualize Proteins on Ordered Mesoporous Silica and for the Realization of Theranostic Nanobioconjugates.

Authors:  Marco Piludu; Luca Medda; Maura Monduzzi; Andrea Salis
Journal:  Int J Mol Sci       Date:  2018-07-08       Impact factor: 5.923

Review 10.  Nanostructured porous Si-based nanoparticles for targeted drug delivery.

Authors:  Mohammad-Ali Shahbazi; Barbara Herranz; Hélder A Santos
Journal:  Biomatter       Date:  2012 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.